Skip to main content
Top
Published in:

Open Access 01-12-2024 | Obesity | Research

Aggregation of cardiovascular risk factors in a cohort of 40-year-olds participating in a population-based health screening program in Sweden

Authors: Beata Borgström Bolmsjö, Emelie Stenman, Anton Grundberg, Kristina Sundquist

Published in: Archives of Public Health | Issue 1/2024

Login to get access

Abstract

Background

It is important to identify and evaluate cardiovascular risk factors at an early stage to address them accordingly. Among the younger population, the metabolic syndrome is less common than in older ages. However, each separate metabolic risk factor still has an additive effect on cardiovascular risk factor burden. Non-metabolic risk factors that occur in the younger population include family history, smoking, psychological distress and socioeconomic vulnerability. In 2021 a voluntary health intervention program was introduced in an urban area in Sweden where a cohort of 40-year-olds was invited for cardiovascular risk identification. The aim of this study was to identify how cardiovascular risk factors tend to aggregate in individuals participating in a voluntary health screening program and how the metabolic risk factors associate with non-metabolic cardiovascular risk factors.

Methods

This was a cross-sectional study with 1831 participants. Data from questionnaires and baseline measurements were used to calculate the prevalence of metabolic- (blood pressure, lipids, fasting plasma glucose, BMI, waist-hip ratio) and non-metabolic risk factors (family history of CVD, smoking, psychological distress, socioeconomic vulnerability) for CVD. SCORE2 was calculated according to the algorithm provided by the SCORE2 working group and ESC (European Society of Cardiology) Cardiovascular Risk Collaboration. Associations among each of the metabolic risk factors and non-metabolic risk factors were estimated using logistic regression and presented as odds ratios (ORs) with 95% confidence intervals (CIs).

Results

More than half of the study population had at least one metabolic risk factor, and more than 1/3 was considered to be suffering from psychological distress. Furthermore, obesity or central obesity demonstrated individual associations with all of the non-metabolic risk factors in the study; smoking (1.49; 1.32–2.63), family history of CVD (1.41; 1.14–1.73), socioeconomic vulnerability (1.60; 1.24–2.07), and psychological distress (1.40; 1.14–1.72). According to SCORE2 25% of the men were at moderate risk (2.5–7.5%) of developing a cardiovascular event within 5–10 years, but only 2% of the women.

Conclusions

Obesity/central obesity should be a prioritized target in health screening programs. The non-metabolic risk factors, socioeconomic vulnerability, and psychological distress should not be ignored and addressed with adequate guidance to create health equity.
Literature
1.
go back to reference Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716–99.CrossRefPubMed Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716–99.CrossRefPubMed
2.
go back to reference Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29(1):5–115.CrossRefPubMed Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29(1):5–115.CrossRefPubMed
3.
go back to reference Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.CrossRefPubMed Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.CrossRefPubMed
4.
go back to reference Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-european case-cohort analysis. Eur Heart J. 2018;39(5):397–406.CrossRefPubMed Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-european case-cohort analysis. Eur Heart J. 2018;39(5):397–406.CrossRefPubMed
5.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed
6.
go back to reference Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed
7.
go back to reference Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2005;28(9):2289–304.CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2005;28(9):2289–304.CrossRefPubMed
8.
go back to reference SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–54.CrossRef SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–54.CrossRef
9.
go back to reference Wu Q, Kling JM. Depression and the risk of myocardial infarction and coronary death: a Meta-analysis of prospective cohort studies. Med (Baltim). 2016;95(6):e2815.CrossRef Wu Q, Kling JM. Depression and the risk of myocardial infarction and coronary death: a Meta-analysis of prospective cohort studies. Med (Baltim). 2016;95(6):e2815.CrossRef
10.
go back to reference Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, et al. Social determinants of Cardiovascular Disease. Circ Res. 2022;130(5):782–99.CrossRefPubMedPubMedCentral Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, et al. Social determinants of Cardiovascular Disease. Circ Res. 2022;130(5):782–99.CrossRefPubMedPubMedCentral
11.
go back to reference Ohlin B, Nilsson PM, Nilsson JA, Berglund G. Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur Heart J. 2004;25(10):867–73.CrossRefPubMed Ohlin B, Nilsson PM, Nilsson JA, Berglund G. Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur Heart J. 2004;25(10):867–73.CrossRefPubMed
12.
go back to reference Valtorta NK, Kanaan M, Gilbody S, Hanratty B. Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing. Eur J Prev Cardiol. 2018;25(13):1387–96.CrossRefPubMed Valtorta NK, Kanaan M, Gilbody S, Hanratty B. Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing. Eur J Prev Cardiol. 2018;25(13):1387–96.CrossRefPubMed
13.
go back to reference Sanchez Rico M, Plessz M, Airagnes G, Ribet C, Hoertel N, Goldberg M, et al. Cardiovascular burden and unemployment: a retrospective study in a large population-based French cohort. PLoS ONE. 2023;18(7):e0288747.CrossRefPubMedPubMedCentral Sanchez Rico M, Plessz M, Airagnes G, Ribet C, Hoertel N, Goldberg M, et al. Cardiovascular burden and unemployment: a retrospective study in a large population-based French cohort. PLoS ONE. 2023;18(7):e0288747.CrossRefPubMedPubMedCentral
14.
go back to reference Hummel B, Harskamp RE, Bolijn R, van Moll EP, Galenkamp H, Mommersteeg PMC, et al. Psychosocial factors may serve as additional eligibility criteria for cardiovascular risk screening in women and men in a multi-ethnic population: the HELIUS study. Prev Med. 2023;172:107515.CrossRefPubMed Hummel B, Harskamp RE, Bolijn R, van Moll EP, Galenkamp H, Mommersteeg PMC, et al. Psychosocial factors may serve as additional eligibility criteria for cardiovascular risk screening in women and men in a multi-ethnic population: the HELIUS study. Prev Med. 2023;172:107515.CrossRefPubMed
15.
go back to reference Lindholm L, Stenling A, Norberg M, Stenlund H, Weinehall L. A cost-effectiveness analysis of a community based CVD program in Sweden based on a retrospective register cohort. BMC Public Health. 2018;18(1):452.CrossRefPubMedPubMedCentral Lindholm L, Stenling A, Norberg M, Stenlund H, Weinehall L. A cost-effectiveness analysis of a community based CVD program in Sweden based on a retrospective register cohort. BMC Public Health. 2018;18(1):452.CrossRefPubMedPubMedCentral
16.
go back to reference Lingfors H, Persson LG. All-cause mortality among young men 24–26 years after a lifestyle health dialogue in a Swedish primary care setting: a longitudinal follow-up register study. BMJ Open. 2019;9(1):e022474.CrossRefPubMedPubMedCentral Lingfors H, Persson LG. All-cause mortality among young men 24–26 years after a lifestyle health dialogue in a Swedish primary care setting: a longitudinal follow-up register study. BMJ Open. 2019;9(1):e022474.CrossRefPubMedPubMedCentral
17.
go back to reference NPO Levnadsvanor. Final report regarding systematic review of the Swedish model for targeted health dialogues [Slutrapport avseende systematisk kunskapsgenomgång av den svenska modellen för Riktade hälsosamtal]. Swedish Association of Local Authorities and Regions; 2022. NPO Levnadsvanor. Final report regarding systematic review of the Swedish model for targeted health dialogues [Slutrapport avseende systematisk kunskapsgenomgång av den svenska modellen för Riktade hälsosamtal]. Swedish Association of Local Authorities and Regions; 2022.
18.
go back to reference Albarqouni L, Montori V, Jorgensen KJ, Ringsten M, Bulbeck H, Johansson M. Applying the time needed to treat to NICE guidelines on lifestyle interventions. BMJ Evid Based Med. 2023;28(5):354–5.CrossRefPubMed Albarqouni L, Montori V, Jorgensen KJ, Ringsten M, Bulbeck H, Johansson M. Applying the time needed to treat to NICE guidelines on lifestyle interventions. BMJ Evid Based Med. 2023;28(5):354–5.CrossRefPubMed
20.
go back to reference Stenman E, Borgström Bolmsjö B, Grundberg A, Sundquist K. Health determinants among participants in targeted health dialogues offered to all 40-year-old individuals in a metropolitan region of 1.4 million people. Scand J Prim Health Care. 2024:1–12. Stenman E, Borgström Bolmsjö B, Grundberg A, Sundquist K. Health determinants among participants in targeted health dialogues offered to all 40-year-old individuals in a metropolitan region of 1.4 million people. Scand J Prim Health Care. 2024:1–12.
22.
go back to reference Persson LG, Lindstrom K, Lingfors H, Bengtsson C, Lissner L. Cardiovascular risk during early adult life. Risk markers among participants in live for life health promotion programme in Sweden. J Epidemiol Community Health. 1998;52(7):425–32.CrossRefPubMedPubMedCentral Persson LG, Lindstrom K, Lingfors H, Bengtsson C, Lissner L. Cardiovascular risk during early adult life. Risk markers among participants in live for life health promotion programme in Sweden. J Epidemiol Community Health. 1998;52(7):425–32.CrossRefPubMedPubMedCentral
23.
go back to reference Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.CrossRefPubMed Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.CrossRefPubMed
24.
go back to reference Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA, /ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168 – 209. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA, /ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168 – 209.
25.
go back to reference World health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. report of a WHO/IDF consultation.; 2006. World health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. report of a WHO/IDF consultation.; 2006.
27.
go back to reference World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva; 1999. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva; 1999.
29.
go back to reference Hong X, Ye Q, He J, Wang Z, Yang H, Qi S, et al. Prevalence and clustering of cardiovascular risk factors: a cross-sectional survey among Nanjing adults in China. BMJ Open. 2018;8(6):e020530.CrossRefPubMedPubMedCentral Hong X, Ye Q, He J, Wang Z, Yang H, Qi S, et al. Prevalence and clustering of cardiovascular risk factors: a cross-sectional survey among Nanjing adults in China. BMJ Open. 2018;8(6):e020530.CrossRefPubMedPubMedCentral
30.
go back to reference Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011(1):Cd001561. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011(1):Cd001561.
31.
go back to reference Björck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009;30(9):1046–56.CrossRefPubMed Björck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009;30(9):1046–56.CrossRefPubMed
32.
go back to reference Sherling DH, Perumareddi P, Hennekens CH. Metabolic syndrome. J Cardiovasc Pharmacol Ther. 2017;22(4):365–7.CrossRefPubMed Sherling DH, Perumareddi P, Hennekens CH. Metabolic syndrome. J Cardiovasc Pharmacol Ther. 2017;22(4):365–7.CrossRefPubMed
33.
go back to reference St Sauver JL, Grossardt BR, Chamberlain AM, Kapoor E, Rocca WA. Synergistic interactions of obesity with sex, education, and smoking and accumulation of multi-morbidity (MM) across the lifespan. J Multimorb Comorb. 2023;13:26335565231160139.CrossRefPubMedPubMedCentral St Sauver JL, Grossardt BR, Chamberlain AM, Kapoor E, Rocca WA. Synergistic interactions of obesity with sex, education, and smoking and accumulation of multi-morbidity (MM) across the lifespan. J Multimorb Comorb. 2023;13:26335565231160139.CrossRefPubMedPubMedCentral
34.
go back to reference Kundi H, Amin ZM, Friedman M, Hagan K, Al-Kindi S, Javed Z, et al. Association of Obesity with Psychological Distress in young adults: patterns by sex and race or ethnicity. JACC Adv. 2024;3(8):101115.CrossRefPubMedPubMedCentral Kundi H, Amin ZM, Friedman M, Hagan K, Al-Kindi S, Javed Z, et al. Association of Obesity with Psychological Distress in young adults: patterns by sex and race or ethnicity. JACC Adv. 2024;3(8):101115.CrossRefPubMedPubMedCentral
36.
go back to reference Albarqouni L, Montori V, Jørgensen KJ, Ringsten M, Bulbeck H, Johansson M. Applying the time needed to treat to NICE guidelines on lifestyle interventions. BMJ Evid Based Med. 2023;28(5):354–5.CrossRefPubMed Albarqouni L, Montori V, Jørgensen KJ, Ringsten M, Bulbeck H, Johansson M. Applying the time needed to treat to NICE guidelines on lifestyle interventions. BMJ Evid Based Med. 2023;28(5):354–5.CrossRefPubMed
37.
go back to reference Ventura HO, Elagizi A, Lavie CJ. Optimal Prevention of Cardiovascular diseases: the earlier the Better∗. J Am Coll Cardiol. 2023;81(12):1162–4.CrossRefPubMed Ventura HO, Elagizi A, Lavie CJ. Optimal Prevention of Cardiovascular diseases: the earlier the Better∗. J Am Coll Cardiol. 2023;81(12):1162–4.CrossRefPubMed
38.
go back to reference Wang Z, Yu D, Osuagwu UL, Pickering K, Baker J, Cutfield R, et al. Health Inequality in eight adverse outcomes over a 25-Year period in a multi-ethnic Population in New Zealand Population with impaired glucose tolerance and/or impaired fasting glucose: an age-period-cohort analysis. Clin Epidemiol. 2023;15:1123–43.CrossRefPubMedPubMedCentral Wang Z, Yu D, Osuagwu UL, Pickering K, Baker J, Cutfield R, et al. Health Inequality in eight adverse outcomes over a 25-Year period in a multi-ethnic Population in New Zealand Population with impaired glucose tolerance and/or impaired fasting glucose: an age-period-cohort analysis. Clin Epidemiol. 2023;15:1123–43.CrossRefPubMedPubMedCentral
39.
go back to reference Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–701.CrossRefPubMed Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–701.CrossRefPubMed
40.
go back to reference Kist JM, Vos RC, Mairuhu ATA, Struijs JN, van Peet PG, Vos HMM, et al. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: an external validation study. EClinicalMedicine. 2023;57:101862.CrossRefPubMedPubMedCentral Kist JM, Vos RC, Mairuhu ATA, Struijs JN, van Peet PG, Vos HMM, et al. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: an external validation study. EClinicalMedicine. 2023;57:101862.CrossRefPubMedPubMedCentral
41.
go back to reference Kimenai DM, Pirondini L, Gregson J, Prieto D, Pocock SJ, Perel P, et al. Socioeconomic deprivation: an important, largely unrecognized risk factor in primary Prevention of Cardiovascular Disease. Circulation. 2022;146(3):240–8.CrossRefPubMedPubMedCentral Kimenai DM, Pirondini L, Gregson J, Prieto D, Pocock SJ, Perel P, et al. Socioeconomic deprivation: an important, largely unrecognized risk factor in primary Prevention of Cardiovascular Disease. Circulation. 2022;146(3):240–8.CrossRefPubMedPubMedCentral
42.
go back to reference Milos Nymberg V, Nymberg P, Pikkemaat M, Calling S, Stenman E, Grundberg A, et al. Lifestyle and cardiovascular risk factors in a Swedish primary care population with self-reported psychiatric symptoms. Prev Med Rep. 2024;37:102547.CrossRefPubMed Milos Nymberg V, Nymberg P, Pikkemaat M, Calling S, Stenman E, Grundberg A, et al. Lifestyle and cardiovascular risk factors in a Swedish primary care population with self-reported psychiatric symptoms. Prev Med Rep. 2024;37:102547.CrossRefPubMed
43.
go back to reference Welch V, Pottie K, Gaudet C, Thuku M, Mallard R, Spenceley S, et al. Realist review of community coalitions and outreach interventions to increase access to primary care for vulnerable populations: a realist review. Arch Public Health. 2023;81(1):115.CrossRefPubMedPubMedCentral Welch V, Pottie K, Gaudet C, Thuku M, Mallard R, Spenceley S, et al. Realist review of community coalitions and outreach interventions to increase access to primary care for vulnerable populations: a realist review. Arch Public Health. 2023;81(1):115.CrossRefPubMedPubMedCentral
Metadata
Title
Aggregation of cardiovascular risk factors in a cohort of 40-year-olds participating in a population-based health screening program in Sweden
Authors
Beata Borgström Bolmsjö
Emelie Stenman
Anton Grundberg
Kristina Sundquist
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Obesity
Obesity
Published in
Archives of Public Health / Issue 1/2024
Electronic ISSN: 2049-3258
DOI
https://doi.org/10.1186/s13690-024-01457-4

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more